: Primary aldosteronism is a frequent cause of secondary hypertension requiring a specific pharmacological treatment with mineralocorticoid receptor antagonist or with unilateral adrenalectomy. These treatments have shown to reduce the excess of cardiovascular risk characteristically associated with this disease. In part I of this consensus, we discussed the procedures for the diagnosis of primary aldosteronism. In the present part II, we address the strategies for the differential diagnosis of primary aldosteronism subtypes and therapy. We also discuss the evaluation of outcomes and provide suggestions for follow-up as well as cardiovascular and metabolic complications specifically associated with primary aldosteronism. Finally, we analyse the principal gaps of knowledge and future challenges for research in this field.
- MeSH
- antihypertenziva farmakologie MeSH
- glukosa metabolismus MeSH
- homeostáza MeSH
- hypertenze farmakoterapie chirurgie patofyziologie MeSH
- inzulinová rezistence MeSH
- katetrizační ablace škodlivé účinky MeSH
- krevní tlak účinky léků MeSH
- ledviny chirurgie inervace patofyziologie MeSH
- léková rezistence MeSH
- lidé MeSH
- randomizované kontrolované studie jako téma MeSH
- sympatektomie škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
